stockrowMoolec Science SA
MLEC Healthcare Biotechnology
Moolec Science SA’s revenue for fiscal 2025 (year ended June 2025) was $333.6 million, up 5,830.7% from fiscal 2024.
- Revenue
- +948.4%
- EPS
- −20.0%
- Free cash flow
- +4.48%
Quarter to December 2025, against a year earlier
Follow MLEC
Alert me
Moolec Science SA (MLEC) Dividend Safety Score
Moolec Science SA's stockrow Dividend Safety Score is 0 out of 100, based on payout ratios, leverage, dividend streak and earnings stability for fiscal 2025.
Dividend Safety Score, annual
Embed this chart
Annual newest first
| Period | Dividend Safety Score | Change (points) |
|---|---|---|
| FY2025 | 0 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Payout of earnings earnings at or below zero | — | — | Fail | 0 |
| Payout of free cash flow free cash flow at or below zero | — | — | Fail | 0 |
| Net debt / EBITDA EBITDA at or below zero | — | — | Fail | 0 |
| Years without a dividend cut | 0 | — | Fail | 0 |
| Years of falling or negative earnings over the last 6 fiscal years | 7 | — | Fail | 0 |
| Dividend Safety Score | Weakly covered | 0 | ||
How the stockrow Dividend Safety Score works
Our own composite, out of 100, for the latest fiscal year: up to 25 points for how little of its earnings the dividend takes, 25 for how little of its free cash flow, 20 for net debt against EBITDA, 20 for the years it has paid without a cut and 10 for how steady earnings per share have been over ten years. How we calculate it.
| 80–100 | Well covered |
|---|---|
| 60–79 | Adequately covered |
| 40–59 | Stretched |
| below 40 | Weakly covered |
Not worked out for a company that pays no regular dividend, for banks and REITs, whose payouts and leverage these measures do not describe, or with fewer than five years of earnings.
Dividend Safety Score against peers
| Company | Dividend Safety Score |
|---|---|
| MLEC Moolec Science SA | 0 |
| BBLG Bone Biologics Corp. compare | — |
| SPRC SciSparc Ltd. compare | — |
| VBIO Valion Bio, Inc. compare | — |
| JAGX Jaguar Animal Health, Inc. compare | — |
| BPTH Bio-Path Holdings, Inc. compare | — |
| CDT CDT Equity Inc. compare | — |
| ATXI Avenue Therapeutics, Inc. compare | — |
| LNAI Lunai Bioworks Inc. compare | — |
What Dividend Safety Score is
The stockrow Dividend Safety Score rates how well earnings and free cash flow cover the dividend, with leverage, the dividend’s record and stable earnings.
Up to 25 points for the payout of earnings, 25 for the payout of free cash flow, 20 for net debt ÷ EBITDA, 20 for the years without a dividend cut and 10 for stable earnings